The shortage of primary care doctors is a national problem. To cope, a large health system in Massachusetts is using an AI tool to screen patients and refer them to other care.
Health Inc.
As insurance prices rise, women puzzle through coverage options for their families
Figuring out the insurance options for families often falls to women. Some say they’re delaying marriage, taking side jobs, and putting their kids on Medicaid as premium prices shoot up in 2026.
Medicare negotiated lower prices for 15 drugs, including 71% off Ozempic and Wegovy
Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia.
New limits on school loans could narrow physician and nurse pipeline, educators warn
Under new Trump administration rules, students won’t be able to borrow as much for medical or nursing school or some other health professions.
White House strikes deals for lower prices on obesity drugs
Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some limitations.
Searching ‘weight’ can bring up Ozempic in results. It’s a drug advertising loophole
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there’s a lot more wiggle room when companies pay to sponsor online search results.
President announces TrumpRx website for drugs, and pricing deal with Pfizer
The Trump administration says it is making deals with drug companies to lower prices U.S. consumers pay for medicines. But key details are missing on how the initiative would work.
Trump’s Medicaid cuts will hurt children’s hospitals
The GOP said its overhaul of Medicaid was aimed at reducing fraud and getting more adult beneficiaries to work. Among the likely side effects: fewer services and doctors for treating sick children.
How rural hospitals are banding together to survive
Independent and rural hospitals are collaborating with their neighbors to shore up their finances instead of joining larger health systems to stay afloat.
Medicare negotiations underway to lower prices for next batch of drugs
In the shadow of President Trump’s efforts to lower drug prices, the Medicare drug price negotiation process that began in the Biden administration continues.


